ArticleNature communications2024

Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells.

Natasha Ramakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.